Mefloquine one. Plasma concentrations of the (–)-enantiomer are significantly higher than those for the (+)-enantiomer, and the pharmacokinetics between the two enantiomers are significantly different. The (+)-enantiomer has a shorter half-life than the (–)-enantiomer. According to some research, the (+)-enantiomer is more effective in treating malaria, and the (–)-enantiomer specifically binds to adenosine receptors in the central nervous system, which may explain some of its psychotropic effects. Mefloquine was formulated at Walter Reed Army Institute of Research (WRAIR) in the 1970s shortly after the end of the Vietnam war. Mefloquine was number 142,490 of a total of 250,000 antimalarial compounds screened
International Association for the Treatment of Sexual Offenders changes as well. A "one size fits all" approach can not be used because youth who have committed sexual crimes are a diverse population, meaning they are all different in numerous ways. Treatment response to sexual abuse by juveniles is based on relapsed prevention, offense cycle, and presumption of sexual dividends. Some research coming out suggests that the successful treatments are those which include community-based and involve supportive adults in the youth's life. Something to keep in mind is label the behavior of the youth, not their identity, because it helps to make sure that youths do not develop a